342 related articles for article (PubMed ID: 10494025)
1. Proteasome inhibitors induce p53/p21-independent apoptosis in human glioma cells.
Wagenknecht B; Hermisson M; Eitel K; Weller M
Cell Physiol Biochem; 1999; 9(3):117-25. PubMed ID: 10494025
[TBL] [Abstract][Full Text] [Related]
2. Influence of p53 and p21Waf1 expression on G2/M phase arrest of colorectal carcinoma HCT116 cells to proteasome inhibitors.
Kim OH; Lim JH; Woo KJ; Kim YH; Jin IN; Han ST; Park JW; Kwon TK
Int J Oncol; 2004 Apr; 24(4):935-41. PubMed ID: 15010833
[TBL] [Abstract][Full Text] [Related]
3. Protease inhibitor-induced apoptosis: accumulation of wt p53, p21WAF1/CIP1, and induction of apoptosis are independent markers of proteasome inhibition.
An WG; Hwang SG; Trepel JB; Blagosklonny MV
Leukemia; 2000 Jul; 14(7):1276-83. PubMed ID: 10914553
[TBL] [Abstract][Full Text] [Related]
4. Proteasome inhibitors induced caspase-dependent apoptosis and accumulation of p21WAF1/Cip1 in human immature leukemic cells.
Naujokat C; Sezer O; Zinke H; Leclere A; Hauptmann S; Possinger K
Eur J Haematol; 2000 Oct; 65(4):221-36. PubMed ID: 11073163
[TBL] [Abstract][Full Text] [Related]
5. Role of p53 in cell cycle regulation and apoptosis following exposure to proteasome inhibitors.
Chen F; Chang D; Goh M; Klibanov SA; Ljungman M
Cell Growth Differ; 2000 May; 11(5):239-46. PubMed ID: 10845424
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of proteasome function induced apoptosis in gastric cancer.
Fan XM; Wong BC; Wang WP; Zhou XM; Cho CH; Yuen ST; Leung SY; Lin MC; Kung HF; Lam SK
Int J Cancer; 2001 Aug; 93(4):481-8. PubMed ID: 11477551
[TBL] [Abstract][Full Text] [Related]
7. Proteasome-dependent regulation of p21WAF1/CIP1 expression.
Blagosklonny MV; Wu GS; Omura S; el-Deiry WS
Biochem Biophys Res Commun; 1996 Oct; 227(2):564-9. PubMed ID: 8878553
[TBL] [Abstract][Full Text] [Related]
8. F9 embryonal carcinoma cells fail to stop at G1/S boundary of the cell cycle after gamma-irradiation due to p21WAF1/CIP1 degradation.
Malashicheva AB; Kislyakova TV; Aksenov ND; Osipov KA; Pospelov VA
Oncogene; 2000 Aug; 19(34):3858-65. PubMed ID: 10951579
[TBL] [Abstract][Full Text] [Related]
9. Proteasome inhibitors induce mitochondria-independent apoptosis in human glioma cells.
Kitagawa H; Tani E; Ikemoto H; Ozaki I; Nakano A; Omura S
FEBS Lett; 1999 Jan; 443(2):181-6. PubMed ID: 9989601
[TBL] [Abstract][Full Text] [Related]
10. In vivo ubiquitination and proteasome-mediated degradation of p53(1).
Maki CG; Huibregtse JM; Howley PM
Cancer Res; 1996 Jun; 56(11):2649-54. PubMed ID: 8653711
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of proteasome inhibitor PS-341-induced G(2)-M-phase arrest and apoptosis in human non-small cell lung cancer cell lines.
Ling YH; Liebes L; Jiang JD; Holland JF; Elliott PJ; Adams J; Muggia FM; Perez-Soler R
Clin Cancer Res; 2003 Mar; 9(3):1145-54. PubMed ID: 12631620
[TBL] [Abstract][Full Text] [Related]
12. p27Kip1 accumulation by inhibition of proteasome function induces apoptosis in oral squamous cell carcinoma cells.
Kudo Y; Takata T; Ogawa I; Kaneda T; Sato S; Takekoshi T; Zhao M; Miyauchi M; Nikai H
Clin Cancer Res; 2000 Mar; 6(3):916-23. PubMed ID: 10741716
[TBL] [Abstract][Full Text] [Related]
13. Proteasome inhibitor-induced apoptosis of glioma cells involves the processing of multiple caspases and cytochrome c release.
Wagenknecht B; Hermisson M; Groscurth P; Liston P; Krammer PH; Weller M
J Neurochem; 2000 Dec; 75(6):2288-97. PubMed ID: 11080180
[TBL] [Abstract][Full Text] [Related]
14. Differential apoptotic response to the proteasome inhibitor Bortezomib [VELCADE, PS-341] in Bax-deficient and p21-deficient colon cancer cells.
Yu J; Tiwari S; Steiner P; Zhang L
Cancer Biol Ther; 2003; 2(6):694-9. PubMed ID: 14688479
[TBL] [Abstract][Full Text] [Related]
15. mdm2 and bax, downstream mediators of the p53 response, are degraded by the ubiquitin-proteasome pathway.
Chang YC; Lee YS; Tejima T; Tanaka K; Omura S; Heintz NH; Mitsui Y; Magae J
Cell Growth Differ; 1998 Jan; 9(1):79-84. PubMed ID: 9438391
[TBL] [Abstract][Full Text] [Related]
16. Proteasome-mediated degradation of BRCA1 protein in MCF-7 human breast cancer cells.
Choi YH
Int J Oncol; 2001 Oct; 19(4):687-93. PubMed ID: 11562742
[TBL] [Abstract][Full Text] [Related]
17. Induction of G1 arrest and selective growth inhibition by lactacystin in human umbilical vein endothelial cells.
Kumeda SI; Deguchi A; Toi M; Omura S; Umezawa K
Anticancer Res; 1999; 19(5B):3961-8. PubMed ID: 10628338
[TBL] [Abstract][Full Text] [Related]
18. Regulation of rheumatoid synoviocyte proliferation by endogenous p53 induction.
Migita K; Tanaka F; Yamasaki S; Shibatomi K; Ida H; Kawakami A; Aoyagi T; Kawabe Y; Eguchi K
Clin Exp Immunol; 2001 Nov; 126(2):334-8. PubMed ID: 11703379
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of ubiquitin-proteasome pathway activates a caspase-3-like protease and induces Bcl-2 cleavage in human M-07e leukaemic cells.
Zhang XM; Lin H; Chen C; Chen BD
Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):127-33. PubMed ID: 10229667
[TBL] [Abstract][Full Text] [Related]
20. Novel dipeptidyl proteasome inhibitors overcome Bcl-2 protective function and selectively accumulate the cyclin-dependent kinase inhibitor p27 and induce apoptosis in transformed, but not normal, human fibroblasts.
An B; Goldfarb RH; Siman R; Dou QP
Cell Death Differ; 1998 Dec; 5(12):1062-75. PubMed ID: 9894613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
